Mikania micrhanta (Wap) : vertus médicinales en extraction alcoolique
Mikania micrhanta (Wap, Lokatè, Lyenn-sèpan, Locataire, liane-à-serpent., Tenant, snake-vine.) — famille Asteracées.
Synonymes scientifiques : Mikania scandens-S Urb-non L, Willoughbya variabilis (Meyen & Walp.) Kuntz.
Cette base documente les extractions alcooliques (éthanol) des substances actives. Notre monographie recense actuellement 20 indications en extraction alcoolique pour cette espèce. Le catalogue Lapo v2 enregistre 95 références scientifiques pour cette espèce (détail intégral dans l’application).
Indications thérapeutiques en extraction alcoolique :
Important — références scientifiques sur cette page publique : seuls de courts extraits de chaque source citée sont présentés (phrases d’abstract sélectionnées), conservés dans leur langue d’origine (le plus souvent l’anglais), sans traduction. Ces extraits ne constituent pas le texte intégral de l’article ni une bibliographie complète. Les fiches de référence complètes et le détail monographique sont disponibles dans l’application Lapo v2 (essai gratuit 30 jours).
-
Infection bacterienne: pied diabétique: Staphylococcus aureus , Staphylococcus epidermis , & Escherichia coli: acne vulgaris
Références scientifiques (courts extraits)
Courts extraits uniquement (pas le texte intégral de l’article). Fiches de référence complètes dans l’application Lapo v2.
-
Selon SUMANTRI IB (2021)
Extrait Antibacterial activity was tested on Staphylococcus aureus, Staphylococcus epidermis, & Escherichia coli. The inhibition zones of antibacterial testing, i.e., S aureus, S epidermis, & E coli, were 10.57 ± 0.26 mm, 9.73 ± 0.21 mm, & 8.4 ± 0.1 mm.
-
Selon Ishak AH (2016)
Extrait Phytochemicals found from various parts of MM have been linked to beneficial medicinal properties such as antioxidant, antimicrobial, antitumour, anti-inflammatory, anti-stress, & also anti-diabetic activities. Mikania micrantha Kunth (Asteraceae) is a perennial creeping vine that can be found in South & North America, Africa, Pacific Islands & Southeast Asia, including Southern China & Malaysia.
-
Selon Koushik Ahammed Md (2020)
Extrait Method: The current research was carried out to evaluate hypoglycemic potential & nephroprotective effect of ethanolic extract of Mikania scandens leaves by using alloxan-induced diabetic nephropathy (DN) mice. Conclusion: Lowering of serum creatinine, uric acid & total protein recommend that the ETOH extract of MS possess potent nephroprotective activity & assure the traditional avail of this plant in the management of diabetes nephropathy.
-
Selon Wan Nurhayati WH (2013)
Extrait The present study investigates the hypoglycaemic effect of Mikania micrantha leaf extract in normal & alloxan induced diabetic rats. The effect of daily oral administration of aqueous extract of Mikania micrantha leaves for a period of 20 days was studied on blood glucose level & hepatic glycogen content in alloxan induced diabetic rats.
-
Selon LHOUVUM V (2023)
Extrait Future research should focus on evaluating the extract's efficacy & safety in animal models & possibly in human clinical trials, paving the way for the development of new antidiabetic therapy,. In this study, our aim was to evaluate the in-vitro glucose uptake inhibitory effect of Mikania micrantha wild leaf extract on yeast cells.
-
Selon SUMANTRI IB (2021)
-
Néphrotoxicité induite pat le diabète : anormalité des paramètres sériques : créatinine, protéine sérique, acide urique
Références scientifiques (courts extraits)
Courts extraits uniquement (pas le texte intégral de l’article). Fiches de référence complètes dans l’application Lapo v2.
-
Selon Koushik Ahammed Md (2020)
Extrait Conclusion: Lowering of serum creatinine, uric acid & total protein recommend that the ETOH extract of MS possess potent nephroprotective activity & assure the traditional avail of this plant in the management of diabetes nephropathy. Method: The current research was carried out to evaluate hypoglycemic potential & nephroprotective effect of ethanolic extract of Mikania scandens leaves by using alloxan-induced diabetic nephropathy (DN) mice.
-
Selon LHOUVUM V (2023)
Extrait Future research should focus on evaluating the extract's efficacy & safety in animal models & possibly in human clinical trials, paving the way for the development of new antidiabetic therapy,. In this study, our aim was to evaluate the in-vitro glucose uptake inhibitory effect of Mikania micrantha wild leaf extract on yeast cells.
-
Selon SUMANTRI IB (2021)
Extrait Purpose: This study aimed to determine the wound healing of nanogels containing MMLE in hyperglycemic rats as a model for diabetic wounds. The parameters observed during the physical testing of nanogels were organoleptic, homogeneity, pH, & size of the particle.
-
Selon Wan Nurhayati WH (2013)
Extrait The present study investigates the hypoglycaemic effect of Mikania micrantha leaf extract in normal & alloxan induced diabetic rats. The effect of daily oral administration of aqueous extract of Mikania micrantha leaves for a period of 20 days was studied on blood glucose level & hepatic glycogen content in alloxan induced diabetic rats.
-
Selon Ishak AH (2016)
Extrait Phytochemicals found from various parts of MM have been linked to beneficial medicinal properties such as antioxidant, antimicrobial, antitumour, anti-inflammatory, anti-stress, & also anti-diabetic activities. Mikania micrantha Kunth (Asteraceae) is a perennial creeping vine that can be found in South & North America, Africa, Pacific Islands & Southeast Asia, including Southern China & Malaysia.
-
Selon Koushik Ahammed Md (2020)
-
Diabete mellitus de type II
Références scientifiques (courts extraits)
Courts extraits uniquement (pas le texte intégral de l’article). Fiches de référence complètes dans l’application Lapo v2.
-
Selon Koushik Ahammed Md (2020)
Extrait Method: The current research was carried out to evaluate hypoglycemic potential & nephroprotective effect of ethanolic extract of Mikania scandens leaves by using alloxan-induced diabetic nephropathy (DN) mice. Conclusion: Lowering of serum creatinine, uric acid & total protein recommend that the ETOH extract of MS possess potent nephroprotective activity & assure the traditional avail of this plant in the management of diabetes nephropathy.
-
Selon SUMANTRI IB (2021)
Extrait Purpose: This study aimed to determine the wound healing of nanogels containing MMLE in hyperglycemic rats as a model for diabetic wounds. The percentage of diabetic wound healing was in the range of 92.79±3.81% to 94.08 ± 2.33% for 14 days of observation.
-
Selon Wan Nurhayati WH (2013)
Extrait The present study investigates the hypoglycaemic effect of Mikania micrantha leaf extract in normal & alloxan induced diabetic rats. The effect of daily oral administration of aqueous extract of Mikania micrantha leaves for a period of 20 days was studied on blood glucose level & hepatic glycogen content in alloxan induced diabetic rats.
-
Selon Ishak AH (2016)
Extrait Phytochemicals found from various parts of MM have been linked to beneficial medicinal properties such as antioxidant, antimicrobial, antitumour, anti-inflammatory, anti-stress, & also anti-diabetic activities. Mikania micrantha Kunth (Asteraceae) is a perennial creeping vine that can be found in South & North America, Africa, Pacific Islands & Southeast Asia, including Southern China & Malaysia.
-
Selon LHOUVUM V (2023)
Extrait Future research should focus on evaluating the extract's efficacy & safety in animal models & possibly in human clinical trials, paving the way for the development of new antidiabetic therapy,. In this study, our aim was to evaluate the in-vitro glucose uptake inhibitory effect of Mikania micrantha wild leaf extract on yeast cells.
-
Selon Koushik Ahammed Md (2020)
D’autres indications (y compris d’autres modes d’extraction le cas échéant), posologies, précautions d’emploi et les <strong>références scientifiques complètes</strong> (fiches intégrales, pas seulement les courts extraits ci-dessus) sont disponibles dans la fiche monographique de l’application Lapo v2.
Évolution de cette fiche publique
Sous le CTA · journal des mises à jour